Results 51 to 60 of about 928,232 (390)

Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma

open access: yesFrontiers in Endocrinology, 2021
BackgroundNeuroendocrine neoplasms are a heterogeneous group of cancers that develop from enterochromaffin cells of the diffuse endocrine system, with an increase in incidents over the last years.
Marta Opalińska   +5 more
doaj   +1 more source

Clinicopathological perspective on ovarian neoplasms in tertiary care hospital, Vijayapura [PDF]

open access: yesAl Ameen Journal of Medical Sciences, 2019
Background and Objective: Ovarian neoplasms are amongst the most common diseases affecting women in India which requires surgical remedy. This study aims to study prevalence of various ovarian neoplasms along with its correlation with various risk ...
Zaryab Zaki   +3 more
doaj  

Cytokines and Prognostic Factors in Epithelial Ovarian Cancer

open access: yesClinical Medicine Insights: Oncology, 2016
Introduction Ovarian cancer has a high mortality and delayed diagnosis. Inflammation is a risk factor for ovarian cancer, and the inflammatory response is involved in almost all stages of tumor development.
Millena Prata Jammal   +4 more
doaj   +1 more source

The Diagnostic Accuracy of Hematologic Parameters, Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio, in Malignant and Benign Epithelial Neoplasms of the Ovary in Philippine General Hospital Service Patients

open access: yesPhilippine Journal of Pathology, 2021
Background and Objectives. Early detection of ovarian neoplasms confer a better outcome and prognosis for patients. Although newer diagnostic modalities have been recently developed, the availability and accessibility of complete blood count parameters ...
Andrea Villaruel, Karen Damian
doaj   +1 more source

Afatinib use in recurrent epithelial ovarian carcinoma. [PDF]

open access: yes, 2019
•Genomic tumor testing is an important tool in guiding treatment for gynecologic malignancies.•Targetable mutations may lead to new therapies in gynecologic cancer treatment.•Her2/neu mutations in serous ovarian carcinomas can be targeted with ERBB2 ...
Alvarez, Edwin A   +3 more
core   +1 more source

Importance of complement system components in ovarian endometriomas. A comparative cohort study [PDF]

open access: yesГинекология
Background. Ovarian endometriomas are one of the most common ovarian neoplasms. There are specific ultrasound criteria for this type of endometriosis; however, in some cases, differential diagnosis from other ovarian tumors is challenging. Aim.
Anna V. Chizhova   +3 more
doaj   +1 more source

Mutations of the BRAF gene in human cancer [PDF]

open access: yes, 2002
Cancers arise owing to the accumulation of mutations in critical genes that alter normal programmes of cell proliferation, differentiation and death. As the first stage of a systematic genome-wide screen for these genes, we have prioritized for analysis ...
Bignell, G.R.   +51 more
core   +1 more source

Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience. [PDF]

open access: yes, 2016
BackgroundHER2/neu overexpression and/or amplification has been widely studied in a number of solid tumors, primarily in the breast. In gynecologic neoplasms, determination of HER2/neu status has not been well studied as a predictive biomarker in anti ...
Apple, Sophia K   +5 more
core   +2 more sources

Sclerosing stromal tumor of the ovary: A case report

open access: yesArchives of Medicine and Health Sciences, 2014
Sclerosing stromal tumors are benign ovarian neoplasms of the sex cord-stromal category, occurring predominantly in the second and third decades of life.
Navjot Kaur   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy